4.4 Review

Gut microbiota and irritable bowel syndrome

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Profiling the human intestinal environment under physiological conditions

Dari Shalon et al.

Summary: This study developed an ingestible device that can collect samples from multiple regions of the human intestinal tract during normal digestion. Multi-omics analysis of the collected samples revealed significant differences in bacteria, phages, host proteins, and metabolites between the intestines and stool. The study provides insights into the roles of the gut microbiome and metabolome in human physiology and disease through non-invasive longitudinal profiling of microorganisms, proteins, and bile acids along the intestinal tract.

NATURE (2023)

Review Gastroenterology & Hepatology

Pathophysiological Commonality Between Irritable Bowel Syndrome and Metabolic Syndrome: Role of Corticotropin-releasing Factor-Toll-like Receptor 4-Proinflammatory Cytokine Signaling

Tsukasa Nozu et al.

Summary: This review discusses the potential pathophysiological link between irritable bowel syndrome (IBS) and metabolic syndrome (MS) with a focus on corticotropin-releasing factor (CRF), Toll-like receptor 4 (TLR4), and proinflammatory cytokine signaling. The review highlights the common mechanisms and potential therapeutic approaches based on epidemiological data.

JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2022)

Article Gastroenterology & Hepatology

The Role of Food in the Treatment of Bowel Disorders: Focus on Irritable Bowel Syndrome and Functional Constipation

Prashant Singh et al.

Summary: Irritable bowel syndrome (IBS) and functional constipation (FC) are common disorders that affect millions of people globally. This article discusses the importance of dietary interventions, including general dietary advice and a low FODMAP diet, in the management of these conditions. It also summarizes the possible mechanisms of FODMAP-mediated IBS, the approach of implementing a low FODMAP diet, and the efficacy of fiber and other dietary interventions in treating IBS and FC.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)

Article Gastroenterology & Hepatology

Efficacy of Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome at 3 Years After Transplantation

Magdy El-Salhy et al.

Summary: According to this study, FMT performed according to the protocol resulted in high treatment response rates and long-term effects, with only a few mild self-limited adverse events.

GASTROENTEROLOGY (2022)

Article Gastroenterology & Hepatology

AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea

Anthony Lembo et al.

Summary: This article presents medication management guidelines for irritable bowel syndrome (IBS). The guidelines provide 8 recommendations for the pharmacological treatment of IBS-D patients, and evaluate the evidence and certainty of different medications.

GASTROENTEROLOGY (2022)

Review Microbiology

Fecal Microbiota Transplantation and Other Gut Microbiota Manipulation Strategies

Gianluca Quaranta et al.

Summary: This review discusses the current strategies for manipulating the gut microbiota and their clinical applications in personalized medicine, including fecal microbiota transplantation, the use of prebiotics and probiotics, and avant-garde approaches such as engineered bacterial strains, phage therapy, and genome editing.

MICROORGANISMS (2022)

Review Microbiology

Gut Microbiota Manipulation in Irritable Bowel Syndrome

Tarek Mazzawi

Summary: Research suggests that manipulating gut microbiota can improve symptoms of irritable bowel syndrome (IBS), with dietary management and other approaches showing promise in changing gut composition and alleviating IBS symptoms. However, more research is needed to identify the exact mixture of beneficial bacteria.

MICROORGANISMS (2022)

Article Nutrition & Dietetics

SCFA: mechanisms and functional importance in the gut

Camille Martin-Gallausiaux et al.

Summary: This article discusses the mechanisms and impact of short-chain fatty acids (SCFA) on gut functions, host immunity, and human health. SCFA, derived from bacterial fermentation of dietary fibers, serve as important fuels for intestinal epithelial cells and modulate various functions to impact intestinal homeostasis.

PROCEEDINGS OF THE NUTRITION SOCIETY (2021)

Review Microbiology

Gut microbiota in human metabolic health and disease

Yong Fan et al.

Summary: The intestinal microbiota plays a significant role in human metabolic health, potentially contributing to the development of common metabolic disorders when dysregulated. Current research is shifting towards cause-and-effect studies and utilizing high-throughput human multi-omics data to identify potential molecular mechanisms behind these associations.

NATURE REVIEWS MICROBIOLOGY (2021)

Review Gastroenterology & Hepatology

The overlap between irritable bowel syndrome and organic gastrointestinal diseases

Imran Aziz et al.

Summary: Irritable bowel syndrome (IBS) is a common functional bowel disorder characterized by symptoms of recurrent abdominal pain and changes in bowel habits. Diagnosis is made by identifying characteristic symptoms and excluding organic gastrointestinal diseases.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Review Biochemistry & Molecular Biology

Enteric Microbiota-Mediated Serotonergic Signaling in Pathogenesis of Irritable Bowel Syndrome

Yoshiyuki Mishima et al.

Summary: Irritable bowel syndrome (IBS) is a chronic functional disorder affecting the gastrointestinal tract, with the dysregulation of the brain-gut-microbiome (BGM) axis potentially playing a major role in its pathogenesis. Serotonin is a key neurotransmitter involved in IBS pathology, and genome studies have identified susceptible genes. Treatment strategies targeting 5-HT have shown effectiveness in certain IBS cases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Gastroenterology & Hepatology

Current status of fecal microbiota transplantation for irritable bowel syndrome

Magdy El-Salhy et al.

Summary: Fecal microbiota transplantation (FMT) shows promise in treating IBS, with the efficacy appearing to be donor-dependent. Factors such as dose, route of administration, and frequency of FMT also play a role in influencing treatment outcomes. Further research is needed to explore the impact of these factors on FMT efficacy in IBS patients.

NEUROGASTROENTEROLOGY AND MOTILITY (2021)

Review Nutrition & Dietetics

Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome

Elemer Simon et al.

Summary: This paper delves into the pathophysiologic mechanisms of irritable bowel syndrome (IBS) and the role of prebiotics, probiotics, and synbiotics in alleviating symptoms. It highlights the importance of technological advancements in understanding the role of probiotics in IBS therapy, and discusses clinical studies testing the efficacy and outcomes of synbiotics as therapy for IBS.

NUTRIENTS (2021)

Article Gastroenterology & Hepatology

The gut virome in Irritable Bowel Syndrome differs from that of controls

S. Coughlan et al.

Summary: The study conducted metagenomic sequencing of fecal Virus-Like Particles (VLPs) from 55 patients with IBS and 51 control individuals. It found significantly lower alpha diversity of viral clusters in IBS, identified core viromes in both IBS and control groups, and noted no significant covariation between the virome and the bacteriome, IBS clinical subtype, or Bile Acid Malabsorption status.

GUT MICROBES (2021)

Review Gastroenterology & Hepatology

Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review

Nikita Hanning et al.

Summary: Barrier dysfunction is present in a significant proportion of adult and all pediatric IBS studies, especially in the IBS-D and PI-IBS subtype. The majority of studies indicated a positive association between loss of barrier function and symptoms such as abdominal pain and changes in the bowel function.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2021)

Article Medicine, General & Internal

Effects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients

Leonilde Bonfrate et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2020)

Review Medicine, General & Internal

Role of gut microbiota in type 2 diabetes pathophysiology

Manoj Gurung et al.

EBIOMEDICINE (2020)

Review Immunology

Interaction Between the Microbiota, Epithelia, and Immune Cells in the Intestine

Hisako Kayama et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)

Article Gastroenterology & Hepatology

Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea

Anthony Lembo et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2020)

Article Biochemistry & Molecular Biology

Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel Syndrome

Ruben A. T. Mars et al.

Review Medicine, General & Internal

Functional Gastrointestinal Disorders 2 Irritable bowel syndrome

Alexander C. Ford et al.

LANCET (2020)

Review Biotechnology & Applied Microbiology

Gut Microbiota-Bile Acid Crosstalk in Diarrhea-Irritable Bowel Syndrome

Kai Zhan et al.

BIOMED RESEARCH INTERNATIONAL (2020)

Review Gastroenterology & Hepatology

Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review

Rapat Pittayanon et al.

GASTROENTEROLOGY (2019)

Review Medicine, General & Internal

The role of diet in irritable bowel syndrome: implications for dietary advice

A. Rej et al.

JOURNAL OF INTERNAL MEDICINE (2019)

Review Medicine, Research & Experimental

Clinical Application and Potential of Fecal Microbiota Transplantation

R. E. Ooijevaar et al.

ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)

Review Gastroenterology & Hepatology

The Gut-Brain Axis and the Microbiome: Mechanisms and Clinical Implications

Vadim Osadchiy et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Review Immunology

The Role of Dietary Nutrients in Inflammatory Bowel Disease

Kohei Sugihara et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Gastroenterology & Hepatology

Functional Bowel Disorders: A Roadmap to Guide the Next Generation of Research

Lin Chang et al.

GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome

Gangping Li et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)

Article Psychiatry

A Microbial Signature of Psychological Distress in Irritable Bowel Syndrome

Johannes Peter et al.

PSYCHOSOMATIC MEDICINE (2018)

Article Microbiology

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome

Xiaojun Zhuang et al.

FRONTIERS IN MICROBIOLOGY (2018)

Review Gastroenterology & Hepatology

The Brain-Gut-Microbiome Axis

Clair R. Martin et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Tumour-associated and non-tumour-associated microbiota in colorectal cancer

Burkhardt Flemer et al.

Article Gastroenterology & Hepatology

Paneth Cell Defects Induce Microbiota Dysbiosis in Mice and Promote Visceral Hypersensitivity

Ambre Riba et al.

GASTROENTEROLOGY (2017)

Review Neurosciences

Interactions between the microbiota, immune and nervous systems in health and disease

Thomas C. Fung et al.

NATURE NEUROSCIENCE (2017)

Review Biochemistry & Molecular Biology

Our Gut Microbiome: The Evolving Inner Self

Parag Kundu et al.

Review Immunology

Dysbiosis and the immune system

Maayan Levy et al.

NATURE REVIEWS IMMUNOLOGY (2017)

Article Gastroenterology & Hepatology

Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating

Tamar Ringel-Kulka et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)

Article Gastroenterology & Hepatology

Similar Fecal Microbiota Signatures in Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Patients With Depression

Yixuan Liu et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Development and Validation of the Rome IV Diagnostic Questionnaire for Adults

Olafur S. Palsson et al.

GASTROENTEROLOGY (2016)

Review Multidisciplinary Sciences

Interactions between the microbiota and pathogenic bacteria in the gut

Andreas J. Baumler et al.

NATURE (2016)

Article Gastroenterology & Hepatology

Interplay between bile acid metabolism and microbiota in irritable bowel syndrome

M. Dior et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2016)

Article Medicine, General & Internal

Irritable bowel syndrome

Paul Enck et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

Article Gastroenterology & Hepatology

The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects

I. Rangel et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)

Article Biotechnology & Applied Microbiology

Diversity of Duodenal and Rectal Microbiota in Biopsy Tissues and Luminal Contents in Healthy Volunteers

Gangping Li et al.

JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2015)

Review Gastroenterology & Hepatology

Why Is Initial Bacterial Colonization of the Intestine Important to Infants' and Children's Health?

Pearl D. Houghteling et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2015)

Review Gastroenterology & Hepatology

Crosstalk at the mucosal border: importance of the gut microenvironment in IBS

Lena Ohman et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)

Article Gastroenterology & Hepatology

Randomised clinical trial: a liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome - a 12 week double-blind study

G. Sisson et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)

Article Gastroenterology & Hepatology

Antibiotic Treatment of Constipation-Predominant Irritable Bowel Syndrome

Mark Pimentel et al.

DIGESTIVE DISEASES AND SCIENCES (2014)

Article Gastroenterology & Hepatology

Brain-Gut Microbiome Interactions and Functional Bowel Disorders

Emeran A. Mayer et al.

GASTROENTEROLOGY (2014)

Article Gastroenterology & Hepatology

Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients

S. Ludidi et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2014)

Article Gastroenterology & Hepatology

Intestinal microbiota in functional bowel disorders: a Rome foundation report

Magnus Simren et al.

Article Gastroenterology & Hepatology

A metagenomic insight into our gut's microbiome

Patricia Lepage et al.

Review Microbiology

The gut microbiota - masters of host development and physiology

Felix Sommer et al.

NATURE REVIEWS MICROBIOLOGY (2013)

Article Gastroenterology & Hepatology

Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome

I. M. Carroll et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2012)

Article Gastroenterology & Hepatology

Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome

H. Duboc et al.

NEUROGASTROENTEROLOGY AND MOTILITY (2012)

Article Gastroenterology & Hepatology

Gastrointestinal Microbiome Signatures of Pediatric Patients With Irritable Bowel Syndrome

Delphine M. Saulnier et al.

GASTROENTEROLOGY (2011)

Article Medicine, General & Internal

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation.

Mark Pimentel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Gastroenterology & Hepatology

Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome

Peter J. Whorwell et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)